Atovaquone Oral Suspension USP, 750 mg per 5 mL sachets, 20 Units x 5 mL cartons, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 50268-086-12.
Published April 24, 2024 · Recall initiated: March 28, 2024
Summary
FDA records drug Class I recall D-0444-2024, published April 24, 2024 and initiated March 28, 2024. Recalling firm: AvKARE; Status: Terminated; Reported quantity: 153 cartons; Lot: Lot: AW0221A Exp. 08/30/2025. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Microbial contamination of a non-sterile product: potential Bacillus cereus contamination.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- AvKARE
- Distributor
- US Nationwide.
- Lot
- Lot: AW0221A Exp. 08/30/2025
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAFludrocortisone Acetate Tablets, USP 0.1mg, Rx Only, 50 Tablets (5 x 10) Unit Dose AVPAK, Manufactured for:November 11, 2026
- FDAAmantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose, Rx Only, Manufactured for: AvKARE,March 4, 2026
- FDARosuvastatin Tablets, USP, 10 mg, Rx Only, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE,January 14, 2026
- FDANorgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg, 3October 15, 2025
- FDADigoxin Tablets, USP 62.5 mcg (0.0625 mg), 100-count bottles, Rx Only, Manufactured by: Novitium Pharma LLC,April 24, 2024
- FDASterile Diluent, HUMALOG U-100 (insulin lispro injection), HUMULIN R U-100 REGULAR (insulin human injection),April 24, 2024
Questions about this recall
Was Atovaquone Oral Suspension USP, 750 mg per 5 mL sachets, 20 Units x 5 mL cartons, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 50268-086-12. recalled?
Yes. FDA published recall D-0444-2024 on April 24, 2024. Reported hazard: Microbial contamination of a non-sterile product: potential Bacillus cereus contamination.
What should I do if I have this product?
Voluntary: Firm initiated · Letter